Figure 2
Figure 2. Targeting to DEC205 results in late endosomal localization, and CD40 and MR antibodies are largely excluded from late endosomes. (A-C) BDCA1+ DCs or (D-E) MoDCs were continuously incubated with 1 μg/mL fluorescently labeled (A,D) anti-DEC205, (B,E) anti-MR, or (C,F) anti-CD40 antibodies for 6 hours at 37°C. In parallel, DCs were incubated with antibodies in the presence of protease and acidification inhibitors leupeptin and NH4Cl (inh). DCs were seeded on coverslips and fixed, followed by staining for the cell surface (HLA-DR) and permeabilization and labeling of early endosomes (EEA1) or late endosomes (Lamp1). Arrows indicate areas of overlap. Images were acquired on a Leica SP5 confocal microscope, 100× oil objective (NA, 1.47), zoom 7. All immunofluorescence experiments were repeated in ≥ 5 independent donors. Scale bar is 5 μm.

Targeting to DEC205 results in late endosomal localization, and CD40 and MR antibodies are largely excluded from late endosomes. (A-C) BDCA1+ DCs or (D-E) MoDCs were continuously incubated with 1 μg/mL fluorescently labeled (A,D) anti-DEC205, (B,E) anti-MR, or (C,F) anti-CD40 antibodies for 6 hours at 37°C. In parallel, DCs were incubated with antibodies in the presence of protease and acidification inhibitors leupeptin and NH4Cl (inh). DCs were seeded on coverslips and fixed, followed by staining for the cell surface (HLA-DR) and permeabilization and labeling of early endosomes (EEA1) or late endosomes (Lamp1). Arrows indicate areas of overlap. Images were acquired on a Leica SP5 confocal microscope, 100× oil objective (NA, 1.47), zoom 7. All immunofluorescence experiments were repeated in ≥ 5 independent donors. Scale bar is 5 μm.

Close Modal

or Create an Account

Close Modal
Close Modal